Results showed that mice treated with AAV9‐shSema3E exhibited lower protein and mRNA levels of Fibronectin, Col1a1, and α‐SMA expression following BLM‐induced pulmonary fibrosis compared to AAV9‐NC mice (Figure 6D,E). Here, ACTA1 is linked to Bloom syndrome.